As of the time of writing, retatrutide has not been approved by the MHRA for use in the United Kingdom, nor has it received a marketing authorisation from the European Medicines Agency (EMA)
[DOI] [PMC free article] [PubMed] [Google Scholar] 144.Ishihara S., Hata K., Hirose K., Okui T., Toyosawa S., Uzawa N., Nishimura R., Yoneda T
Many healthcare providers may not yet be aware of this association because allodynia is not listed on the semaglutide drug label and the research is recent
Adding resistance training 2 to 3 times per week significantly shifts the ratio toward fat loss and muscle preservation
PlexusDx has no partnership with Henry Meds, receives no commission, and prepared this analysis without the companys involvement
A board-certified doctor will review your medical intake form to determine if you are a good candidate